Relationship between onset of eclampsia and AGTR1 gene polymorphisms

Area of Science:

• Genetics
• Obstetrics
• Molecular Biology

Background:

• Eclampsia is a severe pregnancy complication characterized by new-onset hypertension and end-organ dysfunction.
• The angiotensin II receptor type 1 (AGTR1) plays a crucial role in regulating blood pressure and vascular tone.
• Understanding the genetic underpinnings of eclampsia is vital for identifying potential risk factors and therapeutic targets.

Purpose of the Study:

• To investigate the association between angiotensin II receptor type 1 (AGTR1) gene polymorphisms and the occurrence and progression of eclampsia.
• To analyze the correlation between AGTR1 gene variations, AGTR1 expression levels, and clinical parameters in pregnant women with eclampsia.

Main Methods:

• A case-control study involving 200 pregnant women with eclampsia and 200 healthy pregnant women.
• Genome sequencing was employed to identify AGTR1 gene polymorphisms.
• AGTR1 gene expression levels and clinical data were analyzed in both groups.

Main Results:

• Significant differences in allele and genotype distributions of AGTR1 gene polymorphisms (rs1799870, rs144520513, rs529360494) were observed between eclamptic and control groups.
• Specific AGTR1 haplotypes (CGG, TGT) showed differential frequencies, with TGT being higher in the eclampsia group.
• AGTR1 gene polymorphism rs529360494 was associated with reduced AGTR1 expression in eclamptic women, and rs1799870 was linked to prothrombin time, while rs144520513 related to triglyceride and LDL levels.

Conclusions:

• AGTR1 gene polymorphisms are significantly associated with the development and progression of eclampsia.
• Specific AGTR1 variants may influence eclampsia risk by affecting gene expression and clinical manifestations.
• Further research into AGTR1 gene's role could lead to novel diagnostic or therapeutic strategies for eclampsia.